NELLCOR PURITAN BENNETT IRELAND UNLIMITED COMPANY
Location
Founded
1989-05-15
Website
Risk Signals
8568 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Surgical and Medical Instruments and Apparatus), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about NELLCOR PURITAN BENNETT IRELAND UNLIMITED COMPANY
Live alerts from global media, monitored by Business Radar
2023-09-04 (parkstad-limburg.nl)
Companies and governments in Parkstad are joining forces: multi-year 'Medlands' program to bind talent
The companies Medtronic, Abbott and Boston Scientific are starting a multi-year collaboration with the municipalities of Heerlen, Kerkrade and Stadsregio Parkstad under the name 'Medlands Parkstad' to strengthen the medical sector in the region.
Read more
2023-09-01 (limburger.nl)
Medical companies in Parkstad want to use Medland's collaboration to bind talent in the tight labor market
Under the name Medlands Parkstad, the medical technology companies Medtronic and Abbott in Heerlen and Boston Scientific in Kerkrade are starting a program to retain talent. The companies want to be attractive to work for.
Read more
2022-10-13 (investingnews.com)
Bausch Health to Announce Third Quarter 2022 Results on Nov. 3
Bausch Health Companies Inc. (NYSETSX:BHC) ("Bausch Health") will release its third quarter financial results on Thursday, Nov. 3, 2022. Bausch Health will host a conference call and live webcast at 8:00 a.m. U.S. EDT to discuss the results and
Read more
2015-01-26 (massdevice.com)
Medtech approvals: FDA releases November 2014 PMAs
Summary of PMA Originals& Supplements Approved Originals:2 Supplements: 67 Summary of PMA Originals Under Review Total Under Review: 55 Total Active: 26 Total On Hold: 29 Sign up to get our free newsletters delivered straight to your inbox Summary of
Read more
2014-10-01 (massdevice.com)
Medtronic, Covidien name peripherals biz transition team
New rules on inversion deals has Wall Street speculating on the pending $43 billion merger of Medtronic (NYSE:MDT) and Covidien (NYSE:COV), but that hasn’t stopped them from moving forward with their integration plans.
Read more